Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specialises in Recombinant Insulin and cGMP manufactured quaternary ammonium compounds (Quats).
The mission is to enable better medicines by providing sustainable pharmaceutical materials through innovative and customised solutions. Novo Nordisk Pharmatech helps the world´s largest pharmaceutical and biopharmaceutical industries reducing their risk for raw materials by using pharma-grade products with a high level of consistency, purity, quality, and reliability.
Novo Nordisk Pharmatech´ s high purity, non-therapeutic Insulin is sourced directly from parent company Novo Nordisk, the world’s largest insulin producer. Recombinant Insulin stimulates the proliferation of cells, enhances the yield, and is a key component in serum-free growth media for mammalian cells. It is used to manufacture monoclonal antibodies, virus vaccines, gene therapy products and other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
Novo Nordisk Pharmatech manufactures Quats in an unequalled, full cGMP grade, ensuring exceptionally high purity and batch-to-batch consistency. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide/CTAB) is suited for a wide range of pharmaceutical applications that require high purity and quality, such as vaccine production. And as preservatives (excipients) or APIs in many ophthalmic, nasal, oral and topical drugs and in various solutions, ointments, gels, and creams.
More than 70 years of experience has provided the know-how to ensure maximum product purity and keeping impurities to even lower levels than pharmacopeial standards. This has made the company a leading global supplier of high-quality ingredients – enabling the customers to make even better medicines.